{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:57:19Z","timestamp":1793915839957,"version":"4.8.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1301121"],"award-info":[{"award-number":["U1301121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371792"],"award-info":[{"award-number":["81371792"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Program of Guangzhou","award":["2014J4100164"],"award-info":[{"award-number":["2014J4100164"]}]},{"name":"Natural Science Foundation of Guangdong Province","award":["2015A030313050"],"award-info":[{"award-number":["2015A030313050"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501740"],"award-info":[{"award-number":["81501740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.antiviral.2016.12.002","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T21:16:09Z","timestamp":1481231769000},"page":"68-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0808-8698","authenticated-orcid":false,"given":"Lu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersheng","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.12.002_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1743-422X-11-110","article-title":"Inhibition of mTORC1 inhibits lytic replication of Epstein-Barr virus in a cell-type specific manner","volume":"11","author":"Adamson","year":"2014","journal-title":"Virolo. J."},{"key":"10.1016\/j.antiviral.2016.12.002_bib2","doi-asserted-by":"crossref","first-page":"e7124","DOI":"10.1371\/journal.pone.0007124","article-title":"Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling","volume":"4","author":"Balgi","year":"2009","journal-title":"PloS one"},{"key":"10.1016\/j.antiviral.2016.12.002_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1479-5876-8-30","article-title":"Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma","volume":"8","author":"Chen","year":"2010","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.antiviral.2016.12.002_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0065-230X(02)84005-2","article-title":"Genetic requirements for the episomal maintenance of oncogenic herpesvirus genomes","volume":"84","author":"Collins","year":"2002","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.antiviral.2016.12.002_bib5","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1021\/acs.molpharmaceut.5b00098","article-title":"Toward repositioning niclosamide for antivirulence therapy of Pseudomonas aeruginosa lung infections: development of inhalable formulations through nanosuspension Technology","volume":"12","author":"Costabile","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.antiviral.2016.12.002_bib6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/QCO.0b013e3282ef579e","article-title":"Intestinal cestodes","volume":"20","author":"Craig","year":"2007","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.12.002_bib7","first-page":"656","article-title":"Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis. Nature reviews","volume":"2","author":"Damania","year":"2004","journal-title":"Microbiology"},{"key":"10.1016\/j.antiviral.2016.12.002_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0065-230X(01)80012-9","article-title":"Comparative analysis of the transforming mechanisms of Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and Herpesvirus saimiri","volume":"80","author":"Damania","year":"2001","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.antiviral.2016.12.002_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/ml200157f","article-title":"Nitazoxanide disrupts membrane potential and intrabacterial pH homeostasis of Mycobacterium tuberculosis","volume":"2","author":"de Carvalho","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2016.12.002_bib10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tim.2010.04.001","article-title":"NF-kappaB signaling modulation by EBV and KSHV","volume":"18","author":"de Oliveira","year":"2010","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2016.12.002_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/dth.12182","article-title":"Classic Kaposi's sarcoma treated with topical rapamycin","volume":"28","author":"Diaz-Ley","year":"2015","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.antiviral.2016.12.002_bib12","doi-asserted-by":"crossref","first-page":"e78425","DOI":"10.1371\/journal.pone.0078425","article-title":"Identification of three antiviral inhibitors against Japanese encephalitis virus from library of pharmacologically active compounds 1280","volume":"8","author":"Fang","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.antiviral.2016.12.002_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbamcr.2010.03.007","article-title":"Herpesviruses: hijacking the Ras signaling pathway","volume":"1803","author":"Filippakis","year":"2010","journal-title":"Biochimica. Biophysica. Acta"},{"key":"10.1016\/j.antiviral.2016.12.002_bib14","doi-asserted-by":"crossref","first-page":"17530","DOI":"10.1074\/jbc.M112.359638","article-title":"Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling","volume":"287","author":"Fonseca","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.12.002_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.semcdb.2014.09.014","article-title":"The ever-evolving role of mTOR in translation","volume":"36","author":"Fonseca","year":"2014","journal-title":"Seminars Cell. Dev. Biol."},{"key":"10.1016\/j.antiviral.2016.12.002_bib16","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/ijc.25808","article-title":"Rapamycin enhances the activity of oncolytic herpes simplex virus against tumor cells that are resistant to virus replication","volume":"129","author":"Fu","year":"2011","journal-title":"Int. J. Cancer. J. Int. du cancer"},{"key":"10.1016\/j.antiviral.2016.12.002_bib17","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/ajt.12328","article-title":"PI3Kdelta inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein-Barr virus (EBV)+ B cell lymphomas. American journal of transplantation","volume":"13","author":"Furukawa","year":"2013","journal-title":"Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"10.1016\/j.antiviral.2016.12.002_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1172\/JCI40567","article-title":"KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine","volume":"120","author":"Ganem","year":"2010","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.antiviral.2016.12.002_bib19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1476-511X-10-111","article-title":"Induction of Epstein-Barr virus (EBV) lytic cycle in\u00a0vitro causes lipid peroxidation, protein oxidation and DNA damage in lymphoblastoid B cell lines","volume":"10","author":"Gargouri","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.antiviral.2016.12.002_bib20","doi-asserted-by":"crossref","first-page":"e1774","DOI":"10.1038\/cddis.2015.145","article-title":"Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent\/lytic cycle of the virus","volume":"6","author":"Giunco","year":"2015","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.antiviral.2016.12.002_bib21","doi-asserted-by":"crossref","first-page":"12715","DOI":"10.1128\/JVI.02199-14","article-title":"Epstein-barr virus blocks the autophagic flux and appropriates the autophagic machinery to enhance viral replication","volume":"88","author":"Granato","year":"2014","journal-title":"J.\u00a0Virolo."},{"issue":"335","key":"10.1016\/j.antiviral.2016.12.002_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/stke.3352006re4","article-title":"Notch and Wnt signaling: mimicry and manipulation by gamma herpesviruses","volume":"2006","author":"Hayward","year":"2006","journal-title":"Sci. STKE"},{"key":"10.1016\/j.antiviral.2016.12.002_bib23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ajh.21216","article-title":"mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)","volume":"83","author":"Holtan","year":"2008","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.antiviral.2016.12.002_bib24","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/AAC.01952-12","article-title":"New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing","volume":"57","author":"Imperi","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.12.002_bib25","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1158\/0008-5472.CAN-09-3950","article-title":"Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species","volume":"70","author":"Jin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2016.12.002_bib26","doi-asserted-by":"crossref","first-page":"e1002976","DOI":"10.1371\/journal.ppat.1002976","article-title":"Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects","volume":"8","author":"Jurgeit","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2016.12.002_bib27","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1158\/1078-0432.CCR-13-3172","article-title":"mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. Clinical cancer research","volume":"20","author":"Kawada","year":"2014","journal-title":"Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.antiviral.2016.12.002_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcancer.2014.01.002","article-title":"Regulation of the latent-lytic switch in Epstein-Barr virus","volume":"26","author":"Kenney","year":"2014","journal-title":"Seminars Cancer Biol."},{"key":"10.1016\/j.antiviral.2016.12.002_bib29","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1038\/onc.2014.277","article-title":"WNT7A\/beta-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer","volume":"34","author":"King","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2016.12.002_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.pathol.1.110304.100209","article-title":"Spectrum of Epstein-Barr virus-associated diseases","volume":"1","author":"Kutok","year":"2006","journal-title":"Annu. Rev. Pathol-Mech"},{"key":"10.1016\/j.antiviral.2016.12.002_bib31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.biopha.2014.03.018","article-title":"Niclosamide enhances ROS-mediated cell death through c-Jun activation","volume":"68","author":"Lee","year":"2014","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"key":"10.1016\/j.antiviral.2016.12.002_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: one drug, many effects","volume":"19","author":"Li","year":"2014","journal-title":"Cell. Metab."},{"key":"10.1016\/j.antiviral.2016.12.002_bib33","doi-asserted-by":"crossref","first-page":"35769","DOI":"10.1074\/jbc.M113.511212","article-title":"Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 (MTORC1) activity","volume":"288","author":"Li","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.12.002_bib34","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1128\/JVI.00274-15","article-title":"ORF45-Mediated prolonged c-fos accumulation accelerates viral transcription during the late stage of lytic replication of Kaposi's sarcoma-associated herpesvirus","volume":"89","author":"Li","year":"2015","journal-title":"J.\u00a0Virolo."},{"key":"10.1016\/j.antiviral.2016.12.002_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","article-title":"Multi-targeted therapy of cancer by niclosamide: a new application for an old drug","volume":"349","author":"Li","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.antiviral.2016.12.002_bib36","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/JVI.01921-15","article-title":"Epstein-Barr virus BZLF1-mediated downregulation of proinflammatory factors is essential for optimal lytic viral replication","volume":"90","author":"Li","year":"2015","journal-title":"J.\u00a0Virolo."},{"key":"10.1016\/j.antiviral.2016.12.002_bib37","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.3892\/or.2015.3766","article-title":"Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest","volume":"33","author":"Li","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.antiviral.2016.12.002_bib38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2174\/1568009615666150629132157","article-title":"The anthelmintic drug niclosamide inhibits the proliferative activity of human osteosarcoma cells by targeting multiple signal pathways","volume":"15","author":"Liao","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.antiviral.2016.12.002_bib39","doi-asserted-by":"crossref","first-page":"e29290","DOI":"10.1371\/journal.pone.0029290","article-title":"Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt\/beta-catenin pathway","volume":"6","author":"Lu","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.antiviral.2016.12.002_bib40","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/ijc.23415","article-title":"Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression","volume":"122","author":"Ma","year":"2008","journal-title":"Int. J. Cancer J. Int. du Cancer"},{"key":"10.1016\/j.antiviral.2016.12.002_bib41","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1128\/JVI.79.9.5499-5506.2005","article-title":"Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A","volume":"79","author":"Moody","year":"2005","journal-title":"J.\u00a0Virology"},{"key":"10.1016\/j.antiviral.2016.12.002_bib42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/1348-0421.12155","article-title":"Regulation of Epstein-Barr virus reactivation from latency","volume":"58","author":"Murata","year":"2014","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2016.12.002_bib43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/mp.53.5.222","article-title":"Evolutionary aspects of oncogenic herpesviruses","volume":"53","author":"Nicholas","year":"2000","journal-title":"Mol. Patholo. MP"},{"key":"10.1016\/j.antiviral.2016.12.002_bib44","doi-asserted-by":"crossref","first-page":"e14535","DOI":"10.1371\/journal.pone.0014535","article-title":"Rapamycin blocks production of KSHV\/HHV8: insights into the anti-tumor activity of an immunosuppressant drug","volume":"6","author":"Nichols","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.antiviral.2016.12.002_bib45","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1349-7006.2007.00555.x","article-title":"Gamma-herpesviruses and cellular signaling in AIDS-associated malignancies","volume":"98","author":"Noguchi","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.antiviral.2016.12.002_bib46","doi-asserted-by":"crossref","first-page":"e0124595","DOI":"10.1371\/journal.pone.0124595","article-title":"Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus","volume":"10","author":"Rajamuthiah","year":"2015","journal-title":"PloS one"},{"key":"10.1016\/j.antiviral.2016.12.002_bib47","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/ml100146z","article-title":"Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway","volume":"1","author":"Ren","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2016.12.002_bib48","doi-asserted-by":"crossref","first-page":"12065","DOI":"10.1128\/JVI.01431-14","article-title":"Counteracting effects of cellular Notch and Epstein-barr virus EBNA2: implications for stromal effects on virus-host interactions","volume":"88","author":"Rowe","year":"2014","journal-title":"J.\u00a0Virolo."},{"key":"10.1016\/j.antiviral.2016.12.002_bib49","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3851\/IMP1467","article-title":"Herpesviridae and novel inhibitors","volume":"14","author":"Siakallis","year":"2009","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2016.12.002_bib50","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood-2006-06-028092","article-title":"Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in\u00a0vivo by inhibiting autocrine signaling","volume":"109","author":"Sin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2016.12.002_bib51","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1517\/13543776.2014.927442","article-title":"Anti-herpesvirus agents: a patent and literature review (2003 to present)","volume":"24","author":"Skorenski","year":"2014","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.antiviral.2016.12.002_bib52","doi-asserted-by":"crossref","first-page":"8670","DOI":"10.1021\/jm201264t","article-title":"Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication","volume":"54","author":"Stachulski","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.12.002_bib53","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.coi.2004.05.002","article-title":"Immune evasion by gamma-herpesviruses","volume":"16","author":"Stevenson","year":"2004","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2016.12.002_bib54","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/nm.3699","article-title":"Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice","volume":"20","author":"Tao","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2016.12.002_bib55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2006.12.008","article-title":"Targeting mammalian target of rapamycin (mTOR) for health and diseases","volume":"12","author":"Tsang","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2016.12.002_bib56","doi-asserted-by":"crossref","first-page":"e0126088","DOI":"10.1371\/journal.pone.0126088","article-title":"DNA damage signaling is induced in the absence of Epstein-barr virus (EBV) lytic DNA replication and in response to expression of ZEBRA","volume":"10","author":"Wang'ondu","year":"2015","journal-title":"PloS one"},{"key":"10.1016\/j.antiviral.2016.12.002_bib57","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s10637-013-0007-z","article-title":"Preclinical evaluation of the PI3K-mTOR dual inhibitor PF-04691502 as a novel therapeutic drug in nasopharyngeal carcinoma","volume":"31","author":"Wong","year":"2013","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.antiviral.2016.12.002_bib58","series-title":"WHO Model Prescribing Information : Drugs used in parasitic diseases","author":"World Health Organization","year":"1995"},{"key":"10.1016\/j.antiviral.2016.12.002_bib59","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/AAC.48.7.2693-2696.2004","article-title":"Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide","volume":"48","author":"Wu","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.12.002_bib60","doi-asserted-by":"crossref","first-page":"e85887","DOI":"10.1371\/journal.pone.0085887","article-title":"The anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer model","volume":"9","author":"Ye","year":"2014","journal-title":"PloS one"}],"updated-by":[{"DOI":"10.1016\/j.antiviral.2017.01.019","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000}}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216302376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216302376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T17:51:31Z","timestamp":1657993891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216302376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":60,"alternative-id":["S0166354216302376"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.12.002","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.antiviral.2017.01.019","asserted-by":"object"}]},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}